Atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: OR group: > 18 years Structural heart disease / coronary artery disease Scheduled for elective cardiothoracic surgery or endovascular cardiac procedures ER / ICU / CCU group: > 18 years Admitted with (ER), or presenting tachyarrhythmia (ICU / CCU) Outpatient clinic group: > 18 years Congenital heart disease / structural heart disease / coronary artery disease Atrial or ventricular ectopy/tachyarrhythmia
Exclusion criteria
Exclusion criteria: OR group: Hemodynamic instability Usage of inotropic agents Emergency cardiac surgeryPrior left sided radiation of the chest for malignancies ER / ICU / CCU group: Hemodynamic instability Paced atrial rhythmsPacemaker/ICDPresence of assist devices Usage of inotropic agents Emergency cardiac surgery Outpatient clinic: Paced atrial rhythms Pacemaker/ICD Hemodynamic instability Presence of assist devices
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The impact of (t-)LLVS on electrophysiological properties such as conduction block and endo-epicardial asynchrony. | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of (t-)LLVS on incidence and burden of early post-operative AF. To elucidate the correlation between proteostasis marker levels in serum and atrial tissue, and the influence of CANS. To examine the difference between auricular t-LLVS and cervical t-LLVS on atrial electrophysiology. The effect of t-LLVS on termination of tachyarrhythmia The effect of t-LLVS on heart rhythm variability and atrial and ventricular ectopy/tachyarrhythmia in patients with congenital heart disease. | — |
Countries
Netherlands
Contacts
Erasmus MC, Universitair Medisch Centrum Rotterdam